From Delmarva Now
By Brian Witte, Associated Press
July 1, 2019
EXCERPT
In a separate new Maryland law, the state will be able to create a review board on prescription drug costs.
The five board members haven’t been named yet. Supporters say the law is a step toward creating an independent board with the authority to evaluate expensive drugs and recommend methods for addressing high costs.
Last modified: July 1, 2019
